Answers are grounded in this paper and cite their sources.
Despite most of the known cancer biomarkers being glycoproteins, the full diagnostic potential of their glycan alterations remains largely untapped.
No takes yet. Share an insight, caveat, or question.
Svarovsky et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: